医療灌流技術市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00019844
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 173
Buy Now

医療灌流技術市場は、2019 年の 7 億 710 万米ドルから、2027 年までに 9 億 6,260 万米ドルに達すると予想されています。市場は、2020 年から 2027 年にかけて 4.1% の CAGR で成長すると推定されています。



医療灌流技術市場の範囲には、技術、臓器の種類、コンポーネント、地域が含まれます。医療灌流技術の市場は、地域に基づいて、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、中南米に分割されています。このレポートは、市場動向、技術の進歩、市場力学、世界中の主要市場プレーヤーの競争状況分析などのさまざまなパラメーターに重点を置いて、医療灌流技術市場の洞察と詳細な分析を提供します。すべての地域にわたる新型コロナウイルス感染症の影響分析も含まれています。



医療灌流技術市場の有利な地域




市場洞察



細胞ベースの研究活動のための灌流機器



慢性疾患の増加とバイオテクノロジー応用の利点により、細胞ベースの研究活動が大幅に促進されています。細胞ベースのアッセイは、細胞シグナル伝達、増殖、アポトーシス、細胞遺伝学、神経学、がんなど、生物の生物学のさまざまな課題を理解する上で重要な役割を果たします。



細胞ベースのアッセイは次のとおりです。製薬、バイオテクノロジー産業、研究機関、学術研究機関で幅広く実施されています。製薬業界およびバイオ医薬品業界は、医薬品を効率的に商品化するために細胞ベースのアッセイを使用しています。



細胞ベースのアッセイは、臨床試験研究やその他のプロセスのために受託研究機関によっても広く実施されています。がんなどの慢性疾患やその他の遺伝関連研究により、細胞ベースの研究の需要が加速しています。たとえば、Charles River はヒト初代細胞ベースのアッセイのサービスを提供しています。同社が発表した記事によると、細胞ベースのアッセイの開発は今後も続く可能性がある。さらに、同社は、in vitro と in vivo の相関関係が創薬において重要な役割を果たすため、細胞ベースのアッセイが創薬に役立つと述べています。したがって、細胞ベースの研究活動の増加は、予測期間中に医療灌流技術市場を牽引する可能性があります。



技術ベースの洞察



技術に基づいた医療灌流技術市場低体温マシン灌流と正常温マシン灌流に分類されます。 2019 年には、低体温装置潅流セグメントがより大きな市場シェアを占めました。ただし、常温機械潅流セグメントは、予測期間中に市場で 4.4% というより高い CAGR を記録すると推定されています。




グローバル医療灌流技術市場、技術別 - 2019 年および 2027 年




臓器タイプに基づく洞察



臓器タイプに基づく医療灌流テクノロジー市場は心臓、肺、腎臓、肝臓に分割されています。 2019 年、腎臓セグメントが市場で最大のシェアを占めました。しかし、心臓セグメントは、予測期間中に市場で 4.8% という最も高い CAGR を記録すると推定されています。




コンポーネントベース洞察



医療灌流技術市場は、コンポーネントに基づいて、灌流ポンプ、人工肺、人工心肺、モニタリング システム、カニューレなどに分類されます。 2019年、人工肺セグメントはコンポーネント別に市場で最大のシェアを占めました。さらに、心臓血管手術、肝臓移植、腎臓移植の件数の増加により、この分野は今後数年間で最も急速に成長すると予想されています。



戦略的洞察



変化する顧客の需要に応え、世界中でブランド名を維持するために、企業はパートナーシップや合併・買収などの無機的な戦略を採用するのが一般的です。医療灌流技術市場で活動する市場プレーヤーも、世界中で自社のフットプリントと製品ポートフォリオを拡大し、増大する需要に応えるために、製品の発売や拡大などの有機的な戦略を採用しています。



技術別



< ul>
  • 低体温マシン灌流

  • 正常温度マシン灌流


  • 臓器タイプ別





    • 心臓


    • 腎臓

    • 肝臓

    • その他


    コンポーネント別





    • 灌流ポンプ

    • 人工肺

    • 人工心肺

    • モニタリングシステム

    • カニューレ

    • その他

    • 地理別





      • 北アメリカ

        • 米国

        • カナダ

        • メキシコ



      • ヨーロッパ

        • フランス

        • ドイツ

        • イタリア

        • イギリス

        • スペイン

        • >
        • その他のヨーロッパ



      • アジア太平洋 (APAC)

        • 中国

        • インド

        • 南部韓国

        • 日本

        • オーストラリア

        • アジア太平洋地域のその他の地域



      • 中東およびアフリカ (MEA)< ul>
      • 南アフリカ

      • サウジアラビア

      • アラブ首長国連邦

      • MEAの残りの部分



    • 南および中央アメリカ (SCAM)

      • ブラジル

      • アルゼンチン

      • その他の SCAM




    会社概要





    • Getinge AB

    • Medtronic

    • LivaNova PLC

    • XVIVO Perfusion

    • テルモ心臓血管システム法人

    • OrganOx Limited

    • ウォーターズ メディカル システムズ

    • トランスメディックス

    • 臓器回復システム

    • XENIOS AG

    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are Medical Perfusion Technology?

    Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone.

    What are the driving factors for the Medical Perfusion Technology market across the globe?

    Key factors that are driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell-based research activities. However, challenging factors such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to show negative impact for the market in few years ahead.

    What is the cost of Medical Perfusion Technology?

    The costs of the medical perfusion technology are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product types.

    The List of Companies - Medical Perfusion Technology Market

    1. Getting AB
    2. Medtronic              
    3. LivaNova PLC        
    4. Terumo Corporation          
    5. XVIVO Perfusion                 
    6. OrganOx Limited                 
    7. Waters Medical Systems LLC          
    8. TransMedics         
    9. Organ Recovery Systems                 
    10. Xenios AG - a Fresenius Medical Care company

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports